Who Paid My Doc
Jason Begue
Emergency Medicine Birmingham, AL Medical Doctor
NPI 1336120682 CMS profile 1198167
1057 Greystone Cove Dr, Birmingham, AL 35242
General payments
$127
Research payments
$629,913
Ownership & investment interest
$0
Research they led as principal investigator
$1,020,155
Through program year 2023, Jason Begue of Birmingham, AL is reported in the CMS Open Payments database as having received $127 across 8 general payments and $629,913 in research payments paid to them. Separately, studies naming them as principal investigator received $1,020,155 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $31 | 2 | |
| 2023 | Research | $16,791 | 2 | |
| 2022 | General | $33 | 2 | |
| 2022 | Research | $591,281 | 2 | |
| 2021 | General | $63 | 4 | |
| 2021 | Research | $8,541 | 1 | |
| 2020 | Research | $13,300 | 1 |
Beside peers
- Jason Begue
- Emergency Medicine median
- Middle half of Emergency Medicine
- National median
In program year 2025, general payments to Jason Begue were reported at $0. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.
Show as a table
| Year | Jason Begue | Emergency Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $51 | $18–$128 | $163 |
| 2020 | $0 | $29 | $16–$99 | $114 |
| 2021 | $63 | $40 | $18–$124 | $132 |
| 2022 | $33 | $49 | $20–$134 | $149 |
| 2023 | $31 | $51 | $22–$142 | $160 |
| 2024 | $0 | $52 | $22–$150 | $164 |
| 2025 | $0 | $57 | $24–$150 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
117
Drug cost
$816
Branded share of claims
40.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 14 | $442 | |
| Cephalexin | Generic | 15 | $130 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 21 | $70 | |
| Ondansetron Odt Ondansetron | Brand | 12 | $54 | |
| Naproxen | Generic | 21 | $54 | |
| Cyclobenzaprine Hcl | Generic | 18 | $43 | |
| Prednisone | Generic | 16 | $23 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 19 billing codesPaid by Medicare
$27,744
Medicare patients
239
Services billed
297
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 50% | |
| Diabetes | 46% | |
| Ischemic heart disease | 38% | |
| Chronic kidney disease | 35% | |
| Heart failure | 34% | |
| Depression | 31% | |
| Atrial fibrillation | 29% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
14 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Emergency Medicine in Alabama
Related records
Emergency Medicine in Alabama
Practitioners in the same specialty and state, ranked by reported value.
All Emergency Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Alabama
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.